In today’s Academic Minute, the University of Connecticut's Nicholas Leadbeater explains the biochemistry of highly targeted chemotherapy drugs. Leadbeater is an associate professor of organic and inorganic chemistry at Connecticut, where he heads the New Synthetic Methods Group. Find out more about him here. A transcript of this podcast can be found here.
What Others Are Reading